IDLDX — IDL Diagnostics AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK78.32m
- SEK55.16m
- SEK53.11m
Brief: AroCell Q1 Pre-Tax Loss Widens To SEK 5.3 Million
Brief: Arocell Signs Distribution Agreement With Inveniolife
Brief: AroCell Starts Cooperation With Corgenix
Brief: Arocell: New Publication On TK 210 ELISA In Prostate Cancer
Brief: Arocell Q4 Pre-Tax Loss At SEK 5.5 Million
Brief: Arocell: Gongyingshi To Distribute Arocell TK 210 ELISA In China
Brief: Arocell Signs Distribution Agreement With Eurobio Scientific In France
Brief: Arocell Presents Results From The U-CAN TK1 Lymphoma Study
Brief: Arocell July-Sept EBITDA Loss Widens To SEK 4.3 Million
Brief: AroCell Announces Appointment Of New CEO
Brief: AroCell Reveives Patent In The US
Brief: Arocell Q2 Pre-Tax Loss Sek 5.7 Million
Brief: Arocell: Anders Hultman New CFO For Arocell
Brief: AroCell: US Patent Office to Grant Co's Patent Application
Brief: Arocell CFO Ann Hammarstrand Stands Down
Brief: AroCell CEO Jan Stålemark Resigns
Brief: Arocell AB (Publ) Rights Issue Oversubscribed
Brief: AroCell Q1 Pretax Loss At SEK 4.2 Million
Brief: Arocell AB (Publ) Signs Global License Agreement With Roche